Concepedia

Landon C. Brown

LC

12

Publications

418

Citations

11

H-Index

2017

Active since

Affiliations

Duke Cancer Institute(Current)

Duke Medical Center

Duke University

Levine Cancer Institute

Vanderbilt University Medical Center

Landon C. Brown is an author at Duke Cancer Institute specializing in medicine, oncology, and urology.

ORCID

Top concepts

Publications per year

2017–2022

12

Publications

12

<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Landon C. Brown, Matthew D. Tucker, Ramy Sedhom et al. · Journal for ImmunoTherapy of Cancer · 2021 · 109 citations · Full text

<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade

Michael T. Schweizer, Gavin Ha, Roman Gulati et al. · JCO Precision Oncology · 2020 · 88 citations · Full text

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

Matthew D. Tucker, Landon C. Brown, Yu‐Wei Chen et al. · Biomarker Research · 2021 · 41 citations · Full text

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Landon C. Brown, Susan Halabi, Joseph D. Schonhoft et al. · Clinical Cancer Research · 2021 · 35 citations · Full text

A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer

Landon C. Brown, Susan Halabi, Jason A. Somarelli et al. · Prostate Cancer and Prostatic Diseases · 2022 · 34 citations · Full text

, , +7

Rows per page

1–5 of 12